DermaSensor announced today that the FDA cleared its real-time, non-invasive, AI-powered skin cancer evaluation system. Miami-based DermaSensor develops a handheld device that uses ESS, a form of optical spectroscopy. It takes noninvasive samples of tissue, capturing cellular-level information. The technology uses hundreds of wavelengths of light in a manner similar to how sonar uses sound. […]
Oncology
Autonomix completes preclinical transvascular ablation study to treat pancreatic cancer
Autonomix Medical announced today that it completed an animal safety study evaluating its proprietary ablation technology. The Woodlands, Texas-based company designed its tissue ablation technology to address pancreatic cancer-related pain. Current approaches, like opioids or ethanol injections, may only provide limited relief and may lead to risky side effects. The company hopes its proof-of-concept effort […]
SimBioSys wins FDA nod for TumorSight precision medicine platform
SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform. FDA clearance came just days after the company inked a partnership with Mayo Clinic to develop precision medicine solutions. The TumorSight platform takes a patient’s standard-of-care imaging to build a custom 3D model of their tumor. The tool provides […]
Illumina will divest Grail after court backs FTC ruling
Illumina (Nasdaq:ILMN) announced that it plans to divest Grail after a drawn-out legal battle over the $7.1 billion acquisition. In September 2020, Illumina announced an agreement to acquire Grail, a DNA sequencing and array-based tech developer. Grail itself was a startup that initially spun out from the company in 2016. Illumina completed the acquisition in […]
Quantum Surgical makes its first surgical robot sale in the U.S.
Quantum Surgical announced that it made the first sale of its Epione surgical robot platform in the U.S. Popular Equipment Finance (DBA K2 Capital Group), a leader in equipment financing solutions, acquired the Epione robot. The company works with healthcare organizations across the U.S., including a cancer center that used Epione in May 2023. That […]
Noah Medical announces first uses of surgical robot in Asia
Noah Medical announced today that a hospital in Hong Kong conducted the first use of its Galaxy surgical robot system in Asia. Dr. Calvin Ng and Dr. Rainbow Lau performed the first use of Galaxy at Prince of Wales Hospital. The procedure marks the beginning of the first clinical trial of the robotic bronchoscopy system […]
ABK Biomedical’s Eye90 microspheres granted FDA breakthrough device designation
ABK Biomedical today announced its Eye90 microspheres device has received FDA breakthrough device designation. The designation is indicated for the treatment of patients living with unresectable hepatocellular carcinoma (HCC). “We are pleased with the FDA’s decision to grant Breakthrough Device Designation for Eye90 microspheres Y90 radioembolization device. This confirms our belief that Eye90 represents an […]
HistoSonics scores reimbursement win for sonic beam therapy
HistoSonics announced today that the Centers of Medicare & Medicaid Services (CMS) set a new payment rate for its tumor treatment. Minneapolis-based HistoSonics develops a histotripsy treatment for liver tumor procedures. Last month, the FDA granted de novo authorization for its Edison system and novel histotripsy therapy platforms. Edison, an image-guided sonic beam therapy system uses […]
Accuray lays off nearly 6% of global workforce
Accuray is laying off approximately 5.9% of its global workforce in a cost-savings initiative, according to a filing with the Securities and Exchange Commission. The Madison, Wisconsin–based radiation oncology developer reported in September that in accordance with its margin expansion plan, it would commit to a cost-savings initiative designed to reduce operating costs through the […]
iCad sells Xoft brachytherapy business to Elekta
iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million. Elekta is taking over the business, effective immediately, and will make final payments to iCad no later than November 6, 2023. As part of the deal, Elekta will assume all liabilities, and employees will transfer with the business. The […]
FDA grants de novo nod to HistoSonics histotripsy system
HistoSonics announced today that the FDA granted de novo authorization for its Edison system and novel histotripsy therapy platforms. Edison, an image-guided sonic beam therapy system uses advanced imaging and proprietary sensing technology. It delivers non-invasive, personalized treatments with precision and control. The system received FDA investigational device exemption in February. In March, HistoSonics announced […]